169 related articles for article (PubMed ID: 23261152)
41. Vaccination with cathepsin L mimotopes of Fasciola hepatica in goats reduces worm burden, morphometric measurements, and reproductive structures.
Villa-Mancera A; Alcalá-Canto Y; Olivares-Pérez J; Molina-Mendoza P; Hernández-Guzmán K; Utrera-Quintana F; Carreón-Luna L; Olmedo-Juárez A; Reynoso-Palomar A
Microb Pathog; 2021 Jun; 155():104859. PubMed ID: 33845124
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of clorsulon for the treatment of experimentally induced infections of Fasciola hepatica in goats.
Sundlof SF; Bliss EL; Greiner EC; Tran TQ; Wertenberger MA
Am J Vet Res; 1991 Jan; 52(1):111-4. PubMed ID: 2021237
[TBL] [Abstract][Full Text] [Related]
43. Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica.
Pérez-Caballero R; Siles-Lucas M; González-Miguel J; Martínez-Moreno FJ; Escamilla A; Pérez J; Martínez-Moreno A; Buffoni L
Vet Immunol Immunopathol; 2018 Aug; 202():115-121. PubMed ID: 30078585
[TBL] [Abstract][Full Text] [Related]
44. Susceptibility to homologous reinfection with Fasciola gigantica in goats.
Goraish IA; Abdelsalam EB; Tartour G
Rev Elev Med Vet Pays Trop; 1991; 44(1):69-73. PubMed ID: 1775694
[TBL] [Abstract][Full Text] [Related]
45. Lack of humoral and cellular responses against glutathione S-transferases in Fasciola hepatica experimentally infected sheep.
Moreau E; Chauvin A; Boulard C
Vet Res; 1998; 29(6):585-91. PubMed ID: 9851016
[TBL] [Abstract][Full Text] [Related]
46. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings.
Timoteo O; Maco V; Maco V; Neyra V; Yi PJ; Leguía G; Espinoza JR
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):77-86. PubMed ID: 15910994
[TBL] [Abstract][Full Text] [Related]
48. Blood leukocyte responses in rats vaccinated with cDNA encoding glutathioinie-S-transferase of Fasciola hepatica.
Wedrychowicz I; Jedlina-Panasiuk L; Szymanski P; Bieńkowska-Szewczyk K
Wiad Parazytol; 2001; 47(4):551-7. PubMed ID: 16886389
[TBL] [Abstract][Full Text] [Related]
49. [Seasonal variations of Fasciola hepatica infection in goats in the area of Haouz (Morocco)].
Khallaayoune K; el Hari M
Ann Rech Vet; 1991; 22(2):219-26. PubMed ID: 1897872
[TBL] [Abstract][Full Text] [Related]
50. Study of peritoneal macrophage immunophenotype in sheep experimentally infected with Fasciola hepatica.
Ruiz-Campillo MT; Molina-Hernández V; Pérez J; Pacheco IL; Pérez R; Escamilla A; Martínez-Moreno FJ; Martínez-Moreno A; Zafra R
Vet Parasitol; 2018 Jun; 257():34-39. PubMed ID: 29907190
[TBL] [Abstract][Full Text] [Related]
51. Humoral immune responses during experimental infection with Fascioloides magna and Fasciola hepatica in goats and comparison of their excretory/secretory products.
Novobilský A; Kasný M; Mikes L; Kovarcík K; Koudela B
Parasitol Res; 2007 Jul; 101(2):357-64. PubMed ID: 17265088
[TBL] [Abstract][Full Text] [Related]
52. [Comparison of immunologic response in rats immunized orally or intramuscularly with cDNA and recombinant protein of the S-glutathione transferase from Fasciola Hepatica].
Panasiuk LJ
Wiad Parazytol; 2004; 50(4):757-8. PubMed ID: 16862814
[No Abstract] [Full Text] [Related]
53. Fasciola hepatica: partial characterization of circulating antigens.
Rodriguez-Osorio M; Rojas J; Gómez-García V
J Parasitol; 1998 Oct; 84(5):1053-5. PubMed ID: 9794656
[TBL] [Abstract][Full Text] [Related]
54. Responses of Fasciola hepatica infected sheep to various infection levels.
Chauvin A; Moreau E; Boulard C
Vet Res; 2001; 32(1):87-92. PubMed ID: 11254181
[TBL] [Abstract][Full Text] [Related]
55. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines.
Mulcahy G; O'Connor F; Clery D; Hogan SF; Dowd AJ; Andrews SJ; Dalton JP
Res Vet Sci; 1999 Aug; 67(1):27-33. PubMed ID: 10425237
[TBL] [Abstract][Full Text] [Related]
56. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential.
Espino AM; Hillyer GV
J Parasitol; 2004 Aug; 90(4):876-9. PubMed ID: 15357089
[TBL] [Abstract][Full Text] [Related]
57. Purification of native Sigma class glutathione transferase from Fasciola hepatica.
Duncan J; Cutress D; Morphew RM; Brophy PM
Mol Biochem Parasitol; 2018 Jun; 222():45-50. PubMed ID: 29709546
[TBL] [Abstract][Full Text] [Related]
58. Immunization with crude antigens plus aluminium hydroxide protects cattle from Fasciola hepatica infection.
Guasconi L; Serradell MC; Borgonovo J; Garro AP; Varengo H; Caffe G; Masih DT
J Helminthol; 2012 Mar; 86(1):64-9. PubMed ID: 21366935
[TBL] [Abstract][Full Text] [Related]
59. Innate and adaptive resistance of Indonesian Thin Tail sheep to liver fluke: a comparative analysis of Fasciola gigantica and Fasciola hepatica infection.
Pleasance J; Raadsma HW; Estuningsih SE; Widjajanti S; Meeusen E; Piedrafita D
Vet Parasitol; 2011 Jun; 178(3-4):264-72. PubMed ID: 21320754
[TBL] [Abstract][Full Text] [Related]
60. Early migration of immature Fasciola hepatica and associated liver pathology in cattle.
Doy TG; Hughes DL
Res Vet Sci; 1984 Sep; 37(2):219-22. PubMed ID: 6505402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
